愛爾眼科(300015.SZ):擬1400萬元收到南漳愛爾70%股權
格隆匯3月2日丨愛爾眼科(300015.SZ)公佈,公司擬收購南京愛爾安星眼科醫療產業投資中心(有限合夥)(以下簡稱“愛爾安星”)所持有的南漳愛爾眼科醫院有限公司(以下簡稱“南漳愛爾”)70%的股權。
本次收購標的南漳愛爾已形成良好的發展基礎,根據南漳愛爾的資產評估報吿及現有的業務、人才和技術的基本情況,經交易各方協商一致,南漳愛爾70%股權交易價格為1400萬元。收購完成後,公司將持有南漳愛爾70%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.